Sandbox:lipid: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 1: Line 1:
 
{{familytree/start |summary=Sample 1}}
 
{{familytree | boxstyle=background: #FFF0F5; color: #000000;width: 400px; text-align: Center; font-size: 110%; padding: 10px;| | | | | | | | | | | | A01 | | | |A01=<BIG>'''TAVR Imaging Evaluation'''</BIG>}}  
{{familytree/start |summary=Lipid disorders}}
{{familytree | | | | |,|-|-|-|-|-|-|-|^|-|-|-|-|-|-|-|.| | | }}
{{familytree | | | | | | | | | | | | | | | | A01 | | | | | | | A01= '''Lipid disorders'''}}
{{familytree | boxstyle=background: #FFF0F5; color: #000000;width: 150px; text-align: Center; font-size: 90%; padding: 10px;| | | | B01 | | | | | | | | | | | | | | B02 | | |B01=<BIG>'''TAVR CT'''</BIG>|B02=<BIG>'''ECHO'''</BIG>}}
{{familytree | | | | | | | |,|-|-|-|-|-|-|-|-|^|-|-|-|-|-|-|-|-|.| | | | | | }}
{{familytree | | |,|-|^|-|-|-|-|.| | | | | | | |,|-|-|^|-|.|}}
{{familytree | | | | | | | B01 | | | | | | | | | | | | | | | | B02 | B01= '''[[Hypolipoproteinemia]]'''| B02= '''[[Hyperlipoproteinemia]]'''}}
{{familytree | boxstyle=background: #B0E0E6; color: #000000;width: 250px; text-align: Center; font-size: 90%; padding: 5px;| | C01 | | | | | C02 | | | | | | C03 | | |C04|C01=C01}}
{{familytree | | | | |,|-|-|^|-|-|-|.| | | | | | | | | | |,|-|-|^|-|-|-|.| }}
{{familytree | | |!| | |,|-|-|-|+|-|-|-|.| | | |!| | | | |!| }}
{{familytree | | | | C01 | | | | | C02 | | | | | | | | | C03 | | | | | C04 | |C01=Primary|C02=Secondary|C03=Primary|C04=Secondary}}
{{familytree | boxstyle=background: #FFF0F5; color: #000000;width: 70px; text-align: Center; font-size: 70%; padding: 5px;| | D02 | | D03 | |D04| |D05| |!| | | | |!|D02=D02|D03=D03|D04=D04|D05=D05}}
{{familytree | |,|-|-|^|-|-|.| | | |!| | | | | | | | | | |!| | | | | | |!| | | | | }}
{{familytree | |!| | | |!| | | |!| | | |!| | | |!| | | | |!|}}
{{familytree | D01 | | | | D02 | | D03 | | | | | | | | | |!| | | | | | D04 | D01=Low LDL| D02=Low HDL | D03=[[Anemia]], [[Chronic inflammation]], [[Chronic liver disease]], [[Hyperthyroidism]] <br>[[Infection]], [[Malabsorption]], [[Malignancy]], Criticial illness| D04= [[Alcohol]], [[Diabetes]], [[Drug]]s <br> [[Liver disease]], [[Obesity]] <br> [[Renal disease]] <br> [[Smoking]], [[Hypothyroidism]] }}
{{familytree |,|'| | |,|'| | |,|'| | |,|'| | |,|'| | | |,|'|}}
{{familytree | |!| | | | | |!| | | | | |,|-|-|-|-|v|-|-|-|+|-|-|-|v|-|-|-|.| | | }}
{{familytree |!| | | |!| | | |!| | | |!| | | |!| | | | |!| |}}
{{familytree | E01 | | | | E02 | | | | E03 | | | E04 | | E05 | | E06 | | E07 | |E01=[[Abetalipoproteinemia]], [[Hypobetalipoproteinemia]]<br> [[PCSK9 deficiency]], [[Chylomicron retention disease]], Familial combined hypolipidemia|E02=[[LCAT]] deficiency,<br> Apolipoprotein 1 deficiency,<br> Familial hypoalphalipoproteinemia,<br>[[Tangier disease]], FISH eye disease, Familial combined hypolipidemia|E03='''Type I:'''<br> [[Familial hyperchylomicronemia]]|E04='''Type II'''| E05='''Type III:'''<br>[[Dysbetalipoproteinemia]]| E06='''Type IV:'''<br>[[Primary hypertriglyceridemia]]<br>| E07= '''Type V:''' <br>[[Mixed hyperlipoproteinemia]]| }}
{{familytree |boxstyle=background: #FFF0F5; color: #000000;width: 30px; text-align: Center; font-size: 70%; padding: 5px;|)|F01|)| | | |)| | | |)| }}
{{familytree | | | | | | | | | | | | | | | |,|-|-|^|-|-|.| }}
{{familytree | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | | | F01 | | | | F02 | F01='''Type A:'''<br> [[Familial hypercholesterolemia]]| F02= '''Type B:'''<br> [[Familial combined hyperlipidemia]]}}
{{familytree/end}}
{{familytree/end}}
{| class="wikitable"
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 colspan=3  | {{fontcolor|#FFFFFF}}Functional Asseeement
|-
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 colspan=1  | {{fontcolor|#FFFFFF}}Key Steps
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 colspan=1  | {{fontcolor|#FFFFFF}}Essential Elements
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 colspan=1  | {{fontcolor|#FFFFFF}}Additional Details
|-
|style="padding: 5px 5px; background: #F5F5F5;" |Frailty and Disability
|style="padding: 5px 5px; background: #F5F5F5;" |Symptoms
AS severity
|style="padding: 5px 5px; background: #F5F5F5;" |Intensity, acuity
Echo and other imaging
|-
|style="padding: 5px 5px; background: #F5F5F5;" |Baseline clinical data
|style="padding: 5px 5px; background: #F5F5F5;" |Cardiac history
Physical exam and labs
Chest irradiation
Dental evaluation
Allergies
Social support
|style="padding: 5px 5px; background: #F5F5F5;" | Prior cardiac interventions
Routine blood tests, [[PFTs]]
Access issues, other cardiac effects
Treat dental issues before TAVR
[[Contrast]], [[latex]], medications
Recovery, transportation, post discharge planning
|-
|style="background: #F5F5F5; padding: 5px 5px;" rowspan=6 colspan=1" | Major CV comorbidity
|style="background: #F5F5F5;|Coronary artery disease
|style="background: #F5F5F5;|[[Coronary angiography]]
|-
|style="background: #F5F5F5;|LV systolic dysfunction
|style="background: #F5F5F5;|[[LV ejection fraction]]
|-
|style="background: #F5F5F5;|Concurrent valve disease
|style="background: #F5F5F5;|Severe [[Mitral regurgitation|MR]] or [[Mitral stenosis|MS]]
|-
|style="background: #F5F5F5;|[[Pulmonary hypertension]]
|style="background: #F5F5F5;|Assess pulmonary pressures
|-
|style="background: #F5F5F5;|Aortic disease
|style="background: #F5F5F5;|Porcelain aorta (CT scan)
|-
|style="background: #F5F5F5;|Peripheral vascular disease
|style="background: #F5F5F5;|Prohibitive re-entry after previous open heart
surgery (CT scan)
Hostile chest
|-
| style="background: #F5F5F5; padding: 5px 5px;" rowspan=5 colspan=1" |Major non CV comorbidity
|style="background: #F5F5F5;|[[Malignancy]]
|style="background: #F5F5F5;|Remote or active, life expectancy
|-
|style="background: #F5F5F5;|Gastrointestinal and liver disease
|style="background: #F5F5F5;|[[IBD]], [[cirrhosis]], [[Esophageal varices|varices]], [[Gastrointestinal bleeding|GIB]], ability to take
antiplatelets/anticoagulation
|-
|style="background: #F5F5F5;|Kidney disease
|style="background: #F5F5F5;|[[eGFR]] <30cc/min or [[dialysis]]
|-
|style="background: #F5F5F5;|Pulmonary disease
|style="background: #F5F5F5;|Oxygen requirement, [[FEV1]] <50% predicted or
[[DLCO]]<50% predicted
|-
|style="background: #F5F5F5;|Neurological disorders
|style="background: #F5F5F5;|[[Movement disorder|Movement disorders]], [[dementia]]
|}
{| class="wikitable"
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 colspan=3  | {{fontcolor|#FFFFFF|Functional Asseeement}}
|-
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 colspan=1  | {{fontcolor|#FFFFFF|Key Steps}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 colspan=1  | {{fontcolor|#FFFFFF|Essential Elements}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 colspan=1  | {{fontcolor|#FFFFFF|Additional Details}}
|-
! style="background: #4479BA; padding: 5px 5px;" rowspan=2 colspan=1" |{{fontcolor|#FFFFFF|Frailty and Disability}}
|style="background: #F5F5F5;|Frailty Assessment
|style="background: #F5F5F5;|Gait Speed (<0.5m/sec or < 0.83 m/sec with
disability/cognitive impairment)
Frailty (Not Frail or Frail by Assessments)
|-
|style="background: #F5F5F5;|Nutritional Risk/Status
|style="background: #F5F5F5;|Nutritional Risk Status (BMI<21, albumin
<3.5mg/dl, >10-pound weight loss in past year,
or ≤11 on MNA)
|-
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 colspan=1" |{{fontcolor|#FFFFFF|Physical Function}}
| style="background: #F5F5F5;|Physical function and endurance
Independent living
| style="background: #F5F5F5;|6-minute walk <50 m or unable to walk
Dependent in>=1 activities
|-
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 colspan=1" |{{fontcolor|#FFFFFF|Cognitive Function}}
| style="background: #F5F5F5;|Cognitive Impairment
Depression and Prior Disabling Stroke
| style="background: #F5F5F5;|MMSE <24 or dementia
Depression history or positive screen
|-
! style="background: #4479BA; padding: 5px 5px;" rowspan=2 colspan=1" |{{fontcolor|#FFFFFF|Futility}}
|Life expectancy
Lag-time to benefit
|<1 year life expectancy
Survival with benefit of <25% at 2 years
|}

Revision as of 19:07, 11 January 2017

 
 
 
 
 
 
 
 
 
 
 
TAVR Imaging Evaluation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TAVR CT
 
 
 
 
 
 
 
 
 
 
 
 
 
ECHO
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C01
 
 
 
 
{{{ C02 }}}
 
 
 
 
 
{{{ C03 }}}
 
 
{{{C04}}}
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D02
 
D03
 
D04
 
D05
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
{{{F01}}}
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox:lipid&oldid=1282097"